BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19479712)

  • 1. Neuronal differentiation in basal cell carcinoma: possible relationship to Hedgehog pathway activation?
    Gore SM; Kasper M; Williams T; Regl G; Aberger F; Cerio R; Neill GW; Philpott MP
    J Pathol; 2009 Sep; 219(1):61-8. PubMed ID: 19479712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation.
    Marsh D; Dickinson S; Neill GW; Marshall JF; Hart IR; Thomas GJ
    Cancer Res; 2008 May; 68(9):3295-303. PubMed ID: 18451156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Hedgehog signalling promotes pro-tumourigenic integrin expression and function.
    Moutasim KA; Mellows T; Mellone M; Lopez MA; Tod J; Kiely PC; Sapienza K; Greco A; Neill GW; Violette S; Weinreb PH; Marshall JF; Ottensmeier CH; Sayan AE; Jenei V; Thomas GJ
    J Pathol; 2014 Jun; 233(2):196-208. PubMed ID: 24573955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma.
    Regl G; Neill GW; Eichberger T; Kasper M; Ikram MS; Koller J; Hintner H; Quinn AG; Frischauf AM; Aberger F
    Oncogene; 2002 Aug; 21(36):5529-39. PubMed ID: 12165851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter.
    Ikram MS; Neill GW; Regl G; Eichberger T; Frischauf AM; Aberger F; Quinn A; Philpott M
    J Invest Dermatol; 2004 Jun; 122(6):1503-9. PubMed ID: 15175043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas.
    Tang JY; Xiao TZ; Oda Y; Chang KS; Shpall E; Wu A; So PL; Hebert J; Bikle D; Epstein EH
    Cancer Prev Res (Phila); 2011 May; 4(5):744-51. PubMed ID: 21436386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer.
    Mazumdar T; DeVecchio J; Agyeman A; Shi T; Houghton JA
    Oncotarget; 2011 Aug; 2(8):638-45. PubMed ID: 21860067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLI2-specific transcriptional activation of the bone morphogenetic protein/activin antagonist follistatin in human epidermal cells.
    Eichberger T; Kaser A; Pixner C; Schmid C; Klingler S; Winklmayr M; Hauser-Kronberger C; Aberger F; Frischauf AM
    J Biol Chem; 2008 May; 283(18):12426-37. PubMed ID: 18319260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct cellular origin and genetic requirement of Hedgehog-Gli in postnatal rhabdomyosarcoma genesis.
    Rajurkar M; Huang H; Cotton JL; Brooks JK; Sicklick J; McMahon AP; Mao J
    Oncogene; 2014 Nov; 33(46):5370-8. PubMed ID: 24276242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma.
    Kim HS; Kim YS; Lee C; Shin MS; Kim JW; Jang BG
    PLoS One; 2019; 14(11):e0225511. PubMed ID: 31756206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma.
    Neill GW; Ghali LR; Green JL; Ikram MS; Philpott MP; Quinn AG
    Cancer Res; 2003 Aug; 63(15):4692-7. PubMed ID: 12907651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation.
    Canettieri G; Di Marcotullio L; Greco A; Coni S; Antonucci L; Infante P; Pietrosanti L; De Smaele E; Ferretti E; Miele E; Pelloni M; De Simone G; Pedone EM; Gallinari P; Giorgi A; Steinkühler C; Vitagliano L; Pedone C; Schinin ME; Screpanti I; Gulino A
    Nat Cell Biol; 2010 Feb; 12(2):132-42. PubMed ID: 20081843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2.
    Regl G; Kasper M; Schnidar H; Eichberger T; Neill GW; Philpott MP; Esterbauer H; Hauser-Kronberger C; Frischauf AM; Aberger F
    Cancer Res; 2004 Nov; 64(21):7724-31. PubMed ID: 15520176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas.
    Atwood SX; Li M; Lee A; Tang JY; Oro AE
    Nature; 2013 Feb; 494(7438):484-8. PubMed ID: 23446420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
    Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
    Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes.
    Eichberger T; Sander V; Schnidar H; Regl G; Kasper M; Schmid C; Plamberger S; Kaser A; Aberger F; Frischauf AM
    Genomics; 2006 May; 87(5):616-32. PubMed ID: 16434164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic overexpression of the forkhead box transcription factor Foxf1 in Patched-associated tumors.
    Wendling DS; Lück C; von Schweinitz D; Kappler R
    Int J Mol Med; 2008 Dec; 22(6):787-92. PubMed ID: 19020777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of anaplastic lymphoma kinase as a potential therapeutic target in Basal Cell Carcinoma.
    Ning H; Mitsui H; Wang CQ; Suárez-Fariñas M; Gonzalez J; Shah KR; Chen J; Coats I; Felsen D; Carucci JA; Krueger JG
    Oncotarget; 2013 Dec; 4(12):2237-48. PubMed ID: 24163262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal cell carcinoma: a dermatopathological and molecular biological update.
    Saldanha G; Fletcher A; Slater DN
    Br J Dermatol; 2003 Feb; 148(2):195-202. PubMed ID: 12588368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors.
    Tanese K; Emoto K; Kubota N; Fukuma M; Sakamoto M
    J Dermatol; 2018 Oct; 45(10):1181-1186. PubMed ID: 30035333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.